Ga direct naar de inhoud

Ga direct naar de navigatie

Uitgave van

Archief voor de categorie ‘Farma ondernemingen’

Immunovia’s new blood-based testing platform accurately detects non-small cell lung cancer

Immunovia AB announced today that in a new collaborative study with a major global pharma company, Immunovia’s innovative blood-based testing platform, IMMray could differentiate healthy controls from non-small cell lung cancer samples with a 95 % accuracy.

Bron: News-Medical.Net Meer lezen »

Digital birth control app gets FDA nod

Last week the United States Food and Drug Administration (FDA) announced its approval of the digital birth control app to be sold in the US. The app is called “Natural Cycles” and is one of the first medical devices of this kind to receive the FDA nod.

Bron: News-Medical.Net Meer lezen »

Long-acting injection boosts hopes for GSK’s HIV business

A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker’s key HIV business.

Bron: Reuters Health Meer lezen »

Astellas acquires gene therapy group Quethera in £85 million deal

The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. The Tokyo-based pharma company is set to acquire the Cambridge-based firm whose work focuses on the development of novel treatments for ocular disorders such as glaucoma.

Bron: InPharm.com Meer lezen »

FDA approves RNA therapy for rare genetic disease

The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.

Bron: InPharm.com Meer lezen »

US FDA approves Apotex’s potassium chloride oral solution USP

The US Food and Drug Administration (FDA) approved several strengths of potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy (CGT) designation.

Bron: Pharma Biz Meer lezen »

NICE recommends Pfizer’s Besponsa in rare leukaemia following review

Pfizer has revealed that NICE has finally decided to recommend its CD22-targeting monoclonal antibody Besponsa (inotuzumab ozogamicin) in the treatment of relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukaemia in adult patients in whom a tyrosine kinase inhibitor has proven ineffective.

Bron: InPharm.com Meer lezen »

Scientists identify two potential new drug targets for treatment of HIV

Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV-;the virus that causes AIDS-;and the hepatitis C virus.

Bron: News-Medical.Net Meer lezen »

Medicaid expansion increases access to diabetes treatment

Prescriptions for diabetes medications increased in the first two years after states expanded eligibility for Medicaid as part of the Affordable Care Act, compared to states that didn’t expand Medicaid.

Bron: News-Medical.Net Meer lezen »

Celtaxsys cystic fibrosis drug reduces key symptom in mid-stage study

Privately held Celtaxsys Inc said a mid-stage trial testing its experimental cystic fibrosis treatment was successful in reducing a key symptom of the genetic lung disease, but did not improve lung function.

Bron: Reuters Health Meer lezen »

« Oudere artikelen |